Arch Plast Surg.
2020 Sep;47(5):478-482. 10.5999/aps.2020.00108.
Breast implant-associated anaplastic large cell lymphoma in an Asian patient: The first case report from Thailand
- Affiliations
-
- 1PSC Clinic, Nonthaburi, Thailand
- 2Division of Dermatology, Department of Medicine, Thammasat University, Pathumthani, Thailand
- 3Department of Pathology and Forensic Medicine, Thammasat University, Pathumthani, Thailand
- KMID: 2506701
- DOI: http://doi.org/10.5999/aps.2020.00108
Abstract
- Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) has received increasing interest among plastic surgeons as a long-term complication of breast augmentation. Although the prognosis is usually good, mortality is a possible outcome. Most of the cases reported in the past two decades have been from the United States, Europe, and Australia, whereas cases of BIA-ALCL in Asia remain rare. Herein, we describe the first known case of BIA-ALCL in Thailand, in which a 32-year-old woman developed BIA-ALCL 3 years after breast augmentation using textured implants. The patient underwent bilateral removal of the implants and ipsilateral total capsulectomy. This case report—the first of its kind from Thailand—should increase awareness of BIA-ALCL among plastic surgeons in Asia. The true incidence of BIA-ALCL in Asia may be underreported.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Dermatofibroma in Patient with Relapsing Primary Cutaneous Anaplastic Large Cell Lymphoma
- Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL)
- Late seroma complication in a breast augmentation patient with fibrin accumulation: a case report
- Metallic implant-associated lymphoma: ALK-negative anaplastic large cell lymphoma associated with total knee replacement arthroplasty
- Silicone-induced granuloma of breast implant capsule mistaken for breast implant-associated anaplastic large cell lymphoma
